Refine
Year of publication
Document Type
- Article (71) (remove)
Has Fulltext
- yes (71)
Is part of the Bibliography
- no (71)
Keywords
- Magnetic resonance imaging (6)
- CT (4)
- Hepatocellular carcinoma (4)
- MRI (4)
- Artificial intelligence (3)
- Cancer (3)
- microwave ablation (3)
- Algorithms (2)
- Bone density (2)
- DSM (2)
- Dynamic MRI (2)
- Machine learning (2)
- Microwave ablation (2)
- Multidetector computed tomography (2)
- Neoplasms (2)
- Osteoporosis (2)
- Prostate cancer (2)
- Radiomics (2)
- Spine (2)
- Tomography (x-ray computed) (2)
- Transarterial chemoembolization (2)
- breast cancer (2)
- computed tomography (2)
- hepatocellular carcinoma (2)
- liver (2)
- 16 segment AHA model (1)
- Ablation Techniques (1)
- Age determination by skeleton (1)
- Anemia (1)
- Angiography (1)
- Aromatase Inhibitors (1)
- Automated Tube Potential Selection (1)
- Awareness campaign (1)
- Berci needle (1)
- Biopsy (1)
- Blood (1)
- Bone diseases, Metabolic (1)
- Bone marrow (1)
- Breast tumors (1)
- COVID-19 (1)
- CT dual-energy computed tomography (1)
- CT pulmonary angiography (1)
- CT radiation exposure (1)
- CT-guidance (1)
- CT-guided interventions (1)
- Calcium (1)
- Cancer Staging (1)
- Cancer check up (1)
- Cancer staging (1)
- Carcinoma, Ductal, Breast (1)
- Cardiovascular diseases (1)
- Cardiovascular magnetic resonance (1)
- Cell binding (1)
- Cell staining (1)
- Chemoembolization (1)
- Children (1)
- Chondral Lesion (1)
- Cochlear implantation (1)
- Cohort studies (1)
- Colchicum (1)
- Computed tomography imaging (1)
- Computed tomography pulmonary angiography (CTPA) (1)
- Computed tomography, X-ray (1)
- Cone-beam computed tomography (1)
- Congenital (1)
- Contrast agent (1)
- Diagnostic differentiation (1)
- Diagnostic imaging (1)
- Diagnostic markers (1)
- Diffusion magnetic resonance imaging (1)
- Dual-Source CT (1)
- Dual-energy computed tomography (1)
- Dumon stents (1)
- Edema (1)
- Electric stimulation (1)
- Estrogen Receptor Modulators (1)
- Exudates and transudates (1)
- Facial nerve (1)
- Feasibility studies (1)
- Fetal heart (1)
- First experience with patients (1)
- Flow cytometry (1)
- Gadobutrol (1)
- Gadopentate dimeglumine (1)
- Goserelin (1)
- Groin pain (1)
- HCC (1)
- Heart defects (1)
- Herniated disk (1)
- Image processing (1)
- Image processing (computer-assisted) (1)
- In-TIPS thrombosis (1)
- Inguinal hernia (1)
- Inguinal pain (1)
- Intensive care units (1)
- Interventional oncological treatment (1)
- Intervertebral disc displacement (1)
- Kupffer cells (1)
- LNS (1)
- Laser interstitial thermal therapy (1)
- Laser navigation system (1)
- Lateral recess stenosis (1)
- Lipidol (1)
- Lipiodol (1)
- Liver (1)
- Local control (1)
- Low back pain (1)
- Lumbar spinal canal stenosis (1)
- Lumbar spine (1)
- Lung neoplasms (1)
- Lymphangioleiomyomatosis (1)
- MEDIC (1)
- Macrophages (1)
- Mastoiditis (1)
- Medical Oncology (1)
- Medical research (1)
- Metastasis (1)
- Mitomycin C (1)
- Mouse models (1)
- Multidetector Computed Tomography (1)
- Multiparametric MRI (1)
- Myocardial perfusion (1)
- Myocardial segmentation (1)
- Myocarditis (1)
- Necrotic area (1)
- Noninferiority (1)
- Nonpenetrating (1)
- Oncology (1)
- Osteoporotic fractures (1)
- Oswestry Disability Score (1)
- PSA screening (1)
- PSA-Screening (1)
- Patellofemoral Joint (1)
- Percutaneous (1)
- Phantom study (1)
- Phantoms (imaging) (1)
- Physics (1)
- Portal (1)
- Positron emission tomography (1)
- Preclinical research (1)
- Prediction (1)
- Predictive markers (1)
- Preventive medicine (1)
- Prognostic markers (1)
- Prostata-specific antigen (1)
- Prostataspezifisches Antigen (1)
- Prävention (1)
- Quantitative Imaging (1)
- Quantitative features (1)
- Radiology (1)
- Renal lesions (1)
- Response (1)
- Retrospective studies (1)
- Retrospective study (1)
- STIR (1)
- Shunt (1)
- Spinal fractures (1)
- Spinal injuries (1)
- Static MRI (1)
- Statistical analysis (1)
- Sub-segmentation (1)
- Survival (1)
- Survival data (1)
- TACE (1)
- TIPS (1)
- Temporomandibular joint (1)
- Temporomandibular joint dysfunction (1)
- Thrombosis (1)
- Tomography (1)
- Transjugular Intrahepatic Portosystemic Shunt (1)
- Translational research (1)
- Treatment outcome (1)
- Truncus arteriosus (1)
- Tumor volume (1)
- UWB diagnostics (1)
- Vaccination (1)
- Vasculitis (1)
- Vertebral body (1)
- Virtual noncalcium reconstructions (1)
- Vorsorgeuntersuchung (1)
- Wounds (1)
- X-ray computed (1)
- abdominal imaging (1)
- airway (1)
- amino acids (1)
- angiography (1)
- aortic stenosis (1)
- beads (1)
- biopsy (1)
- cardiac magnetic resonance (1)
- cardiac remodeling (1)
- chronic liver disease (CLD) (1)
- cisplatin (1)
- colorectal cancer (1)
- colorectal cancer (CRC) (1)
- colorectal cancer liver metastases (CRLM) (1)
- computer tomography (1)
- computer-assisted (1)
- cone-beam computed tomography (CBCT) (1)
- cone-beam computer tomography (1)
- conventional/traditional transarterial chemoembolization (cTACE) (1)
- critical care unit (1)
- critical ill patients (1)
- denervation (1)
- diagnostic imaging (1)
- drug-eluting beads TACE (DEB-TACE) (1)
- dual-energy (1)
- electromagnetic navigation bronchoscopy (EMN, ENB) (1)
- heart failure (1)
- hepatocellular carcinoma (HCC) (1)
- high-pitch (1)
- imaging (1)
- in vivo dosimetry (1)
- interventional radiology (1)
- intraarterial therapy (1)
- intratumoral (1)
- irinotecan-loaded drug-eluting beads TACE (DEBIRI-TACE) (1)
- laser-induced thermotherapy (1)
- lipiodol (1)
- liver metastases (1)
- livermetastases of colorectal cancer (1)
- locoregional chemotherapy (1)
- low-dose imaging (1)
- lung cancer (1)
- mantle cell lymphoma (1)
- microwave breast imaging (1)
- multidetector computed tomography (1)
- myocardial fibrosis (1)
- non‑Hodgkin's lymphoma (1)
- oval split ring resonator (1)
- overall survival (OS) (1)
- papilloma (1)
- patient study (1)
- percutaneous thermal ablation (1)
- peripheral blood stem cell transplant (1)
- portal vein (1)
- progression-free survival (PFS) (1)
- pulmonary hypertension (1)
- radiation (1)
- radiation dosage (1)
- radiation dosimetry (1)
- radiation protection (1)
- radiomics (1)
- rats (1)
- retuximab (1)
- scar (1)
- sepsis (1)
- sex‑determining region Y-box 11 (1)
- skin involvement (1)
- solitary pulmonary nodule (1)
- spine (1)
- stent (1)
- theranostics (1)
- thrombosis (1)
- tracheobronchomalacia (1)
- transarterial chemoembolization (TACE) (1)
- transbronchial biopsy (TBB) (1)
- tumor response (1)
- vertebroplasty (1)
- Öffentlichkeit (1)
Institute
- Medizin (71)
- Informatik und Mathematik (3)
- Informatik (1)
- Physik (1)
- Sonderforschungsbereiche / Forschungskollegs (1)
Objective: To determine the early treatment response after microwave ablation (MWA) of inoperable lung neoplasms using the apparent diffusion coefficient (ADC) value calculated 24 h after the ablation.
Materials and methods: This retrospective study included 47 patients with 68 lung lesions, who underwent percutaneous MWA from January 2008 to December 2017. Evaluation of the lesions was done using MRI including DWI sequence with ADC value calculation pre-ablation and 24 h post-ablation. DWI-MR was performed with b values (50, 400, 800 mm2/s). The post-ablation follow-up was performed using chest CT and/or MRI within 24 h following the procedure; after 3, 6, 9, and 12 months; and every 6 months onwards to determine the local tumor response. The post-ablation ADC value changes were compared to the end response of the lesions.
Results: Forty-seven patients (mean age: 63.8 ± 14.2 years, 25 women) with 68 lesions having a mean tumor size of 1.5 ± 0.9 cm (range: 0.7–5 cm) were evaluated. Sixty-one lesions (89.7%) showed a complete treatment response, and the remaining 7 lesions (10.3%) showed a local progression (residual activity). There was a statistically significant difference regarding the ADC value measured 24 h after the ablation between the responding (1.7 ± 0.3 × 10−3 mm2/s) and non-responding groups (1.4 ± 0.3 × 10−3 mm2/s) with significantly higher values in the responding group (p = 0.001). A suggested ADC cut-off value of 1.42 could be used as a reference point for the post-ablation response prediction (sensitivity: 66.67%, specificity: 84.21%, PPV: 66.7%, and NPV: 84.2%). No significant difference was reported regarding the ADC value performed before the ablation as a factor for the prognosis of treatment response (p = 0.86).
Conclusion: ADC value assessment following ablation may allow the early prediction of treatment efficacy after MWA of inoperable lung neoplasms.
Key Points
• ADC value calculated 24 h post-treatment may allow the early prediction of MWA efficacy as a treatment of pulmonary tumors and can be used in the early immediate post-ablation imaging follow-up.
• The pre-treatment ADC value of lung neoplasms is not different between the responding and non-responding tumors.
Purpose: To stratify differences in visual semantic and quantitative imaging features in intensive care patients with nonspecific mastoid effusions versus patients with acute mastoiditis (AM) requiring surgical treatment. Methods: We included 48 patients (male, 28; female, 20; mean age, 59.5 ± 18.1 years) with mastoid opacification (AM, n = 24; control, n = 24) who underwent clinically indicated cerebral CT between 12/2007 and 07/2018 in this retrospective study. Semantic features described the extend and asymmetry of mastoid and middle-ear cavity opacification and complications like erosive changes. Minimum, maximum and mean Hounsfield unit (HU) values were obtained as quantitative features. We analyzed the features employing univariate testing. Results: Compared to intensive care patients, AM patients revealed asymmetric mastoid or middle-ear cavity opacification (likelihood-ratio (LR) < 0.001). Applying a dedicated threshold of the extent of opacification, AM patients reached significance levels of LR = 0.042 and 0.002 for mastoid and middle-ear cavity opacification. AM cases showed higher maximum and mean HU values (p = 0.009, p = 0.024). Conclusions: We revealed that the extent and asymmetry of mastoid and middle-ear cavity opacification differs significantly between AM patients and intensive care patients. Multicenter research is needed to expand our cohort and possibly pave the way to build a non-invasive predictive model for AM in the future.
Background: To assess the potential of radiomic features to quantify components of blood in intraaortic vessels to non-invasively predict moderate-to-severe anemia in non-contrast enhanced CT scans. Methods: One hundred patients (median age, 69 years; range, 19–94 years) who received CT scans of the thoracolumbar spine and blood-testing for hemoglobin and hematocrit levels ± 24 h between 08/2018 and 11/2019 were retrospectively included. Intraaortic blood was segmented using a spherical volume of interest of 1 cm diameter with consecutive radiomic analysis applying PyRadiomics software. Feature selection was performed applying analysis of correlation and collinearity. The final feature set was obtained to differentiate moderate-to-severe anemia. Random forest machine learning was applied and predictive performance was assessed. A decision-tree was obtained to propose a cut-off value of CT Hounsfield units (HU). Results: High correlation with hemoglobin and hematocrit levels was shown for first-order radiomic features (p < 0.001 to p = 0.032). The top 3 features showed high correlation to hemoglobin values (p) and minimal collinearity (r) to the top ranked feature Median (p < 0.001), Energy (p = 0.002, r = 0.387), Minimum (p = 0.032, r = 0.437). Median (p < 0.001) and Minimum (p = 0.003) differed in moderate-to-severe anemia compared to non-anemic state. Median yielded superiority to the combination of Median and Minimum (p(AUC) = 0.015, p(precision) = 0.017, p(accuracy) = 0.612) in the predictive performance employing random forest analysis. A Median HU value ≤ 36.5 indicated moderate-to-severe anemia (accuracy = 0.90, precision = 0.80). Conclusions: First-order radiomic features correlate with hemoglobin levels and may be feasible for the prediction of moderate-to-severe anemia. High dimensional radiomic features did not aid augmenting the data in our exemplary use case of intraluminal blood component assessment.
Diagnostic value of dynamic magnetic resonance imaging of temporomandibular joint dysfunction
(2021)
Background: To estimate the diagnostic value of dynamic magnetic resonance imaging (MRI) for the assessment of the temporomandibular joint (TMJ) compared to standard static MRI sequences in patients with TMJ dysfunction (TMD).
Methods and materials: This retrospective study included 71 patients with clinical diagnose of TMD. We acquired 5 static T1- and T2-weighted sequences in parasagittal and paracoronal views and one dynamic sequence (trueFISP) in parasagittal view for each TMJ. Image analysis included evaluation of morphology and function of intra-articular structures and rating of the dynamic images as more, equally, or less informative compared to static MRI sequences.
Results: Mean age was 35.0 ± 14.7 years and 50/71 (70.4%) were female. 127/142 (89.4%) TMJs were of diagnostic quality. 42/127 (33.1%) TMJs showed no disc displacement (DD), 56 (44.1%) had DD with disc reduction (DDwR), and 29 (22.8%) had DD without disc reduction (DDwoR). In 38/127 (29.9%) TMJs, dynamic images were rated “more informative”, in 84/127 (66.2%) “equally informative”, and in 5/127 (3.9%) “less informative” compared to solely static images. Overall, 27/71 (38.0%) patients benefited from additional dynamic sequences compared to solely static images. Dynamic images were “more informative” in TMJs with DDwR (23/56 [41.1%], p < 0.001) and in TMJs with DDwoR (13/29 [44.8%], p = 0.007), while it had no beneficial value for TMJ without DD. For evaluation of joint effusion, static T2-weighted images were rated better in 102/127 (80.3%) TMJs compared to dynamic images (<0.001).
Conclusion: Dynamic MRI sequences are beneficial for the evaluation of morphology and function of the TMJ compared to static sequences, especially in patients with temporomandibular disc displacement.
Background: Various studies have been made about the most effective and safest type of treatment for vertebral compression fractures (VCFs). Long-term results are needed for qualitative evaluation.
Purpose: The purpose of the study is to evaluate the effectiveness of percutaneous vertebroplasty (PVP) and percutaneous kyphoplasty (PKP) procedures for VCFs.
Materials and Methods: Forty-nine patients who received either PVP or PKP between 2002 and 2015 returned a specially developed questionnaire and were included in a cross-sectional outcome analysis. The questionnaire assessed pain development by use of a visual analog scale (VAS). Imaging data (CT scans) were retrospectively analyzed for identification of cement leakage.
Results: Patients’ VAS scores significantly decreased after treatment (7.0 ± 3.4 => 3.7 ± 3.4), (p < 0.001). The average pain reduction in patients treated with PVP was −3.3 ± 3.8 (p < 0.001) (median −3.5) and −4.0 ± 3.9 (p < 0.001) (median −4.5) in patients treated with PKP. Fifteen Patients (41.7%) receiving PVP and four patients (30.7%) receiving PKP experienced recurrence of pain. Cement leakage occurred in 10 patients (22.73%). Patients with cement leakage showed comparable VAS scores after treatment (6.8 ± 3.5 => 1.4 ± 1.6), (p = 0.008). Thirty-nine patients reported an increase in mobility (79.6%) and 41 patients an improvement in quality of life (83.7%).
Conclusion: Pain reduction by means of PVP or PKP in patients with VCFs was discernible over the period of observation. Percutaneous vertebroplasty and PKP contribute to the desired treatment results. However, the level of low pain may not remain constant.
Our purpose was to analyze the robustness and reproducibility of magnetic resonance imaging (MRI) radiomic features. We constructed a multi-object fruit phantom to perform MRI acquisition as scan-rescan using a 3 Tesla MRI scanner. We applied T2-weighted (T2w) half-Fourier acquisition single-shot turbo spin-echo (HASTE), T2w turbo spin-echo (TSE), T2w fluid-attenuated inversion recovery (FLAIR), T2 map and T1-weighted (T1w) TSE. Images were resampled to isotropic voxels. Fruits were segmented. The workflow was repeated by a second reader and the first reader after a pause of one month. We applied PyRadiomics to extract 107 radiomic features per fruit and sequence from seven feature classes. We calculated concordance correlation coefficients (CCC) and dynamic range (DR) to obtain measurements of feature robustness. Intraclass correlation coefficient (ICC) was calculated to assess intra- and inter-observer reproducibility. We calculated Gini scores to test the pairwise discriminative power specific for the features and MRI sequences. We depict Bland Altmann plots of features with top discriminative power (Mann–Whitney U test). Shape features were the most robust feature class. T2 map was the most robust imaging technique (robust features (rf), n = 84). HASTE sequence led to the least amount of rf (n = 20). Intra-observer ICC was excellent (≥ 0.75) for nearly all features (max–min; 99.1–97.2%). Deterioration of ICC values was seen in the inter-observer analyses (max–min; 88.7–81.1%). Complete robustness across all sequences was found for 8 features. Shape features and T2 map yielded the highest pairwise discriminative performance. Radiomics validity depends on the MRI sequence and feature class. T2 map seems to be the most promising imaging technique with the highest feature robustness, high intra-/inter-observer reproducibility and most promising discriminative power.
Purpose: To investigate the diagnostic performance of noise-optimized virtual monoenergetic images (VMI+) in dual-energy CT (DECT) of portal vein thrombosis (PVT) compared to standard reconstructions. Method: This retrospective, single-center study included 107 patients (68 men; mean age, 60.1 ± 10.7 years) with malignant or cirrhotic liver disease and suspected PVT who had undergone contrast-enhanced portal-phase DECT of the abdomen. Linearly blended (M_0.6) and virtual monoenergetic images were calculated using both standard VMI and noise-optimized VMI+ algorithms in 20 keV increments from 40 to 100 keV. Quantitative measurements were performed in the portal vein for objective contrast-to-noise ratio (CNR) calculation. The image series showing the greatest CNR were further assessed for subjective image quality and diagnostic accuracy of PVT detection by two blinded radiologists. Results: PVT was present in 38 subjects. VMI+ reconstructions at 40 keV revealed the best objective image quality (CNR, 9.6 ± 4.3) compared to all other image reconstructions (p < 0.01). In the standard VMI series, CNR peaked at 60 keV (CNR, 4.7 ± 2.1). Qualitative image parameters showed the highest image quality rating scores for the 60 keV VMI+ series (median, 4) (p ≤ 0.03). The greatest diagnostic accuracy for the diagnosis of PVT was found for the 40 keV VMI+ series (sensitivity, 96%; specificity, 96%) compared to M_0.6 images (sensitivity, 87%; specificity, 92%), 60 keV VMI (sensitivity, 87%; specificity, 97%), and 60 keV VMI+ reconstructions (sensitivity, 92%; specificity, 97%) (p ≤ 0.01). Conclusions: Low-keV VMI+ reconstructions resulted in significantly improved diagnostic performance for the detection of PVT compared to other DECT reconstruction algorithms.
Purpose: The aim of this study was to prospectively compare the therapy response and safety of microwave (MWA) and radiofrequency ablation (RFA) for the treatment of liver metastases using a dual ablation system.
Methods: Fifty patients with liver metastases (23 men, mean age: 62.8 ± 11.8 years) were randomly assigned to MWA or RFA for thermal ablation using a one generator dual ablation system. Magnetic resonance imaging (MRI) was acquired before treatment and 24 h post ablation. The morphologic responses to treatment regarding size, volume, necrotic areas, and diffusion characteristics were evaluated by MRI. Imaging follow-up was obtained for one year in three months intervals, whereas clinical follow-up was obtained for two years in all patients.
Results: Twenty-six patients received MWA and 24 patients received RFA (mean diameter: 1.6 cm, MWA: 1.7 cm, RFA: 1.5 cm). The mean volume 24 h after ablation was 37.0 cm3 (MWA: 50.5 cm3, RFA: 22.9 cm3, P < 0.01). The local recurrence rate was 0% (0/26) in the MWA-group and 8.3% (2/24) in the RFA-group (P = 0.09). The rate of newly developed malignant formations was 38.0% (19/50) for both groups (MWA: 38.4%, RFA: 37.5%, P = 0.07). The overall survival rate was 70.0% (35/50) after two years (MWA: 76.9%, RFA: 62.5%, P = 0.60). No major complications were reported.
Conclusion: In conclusion, MWA and RFA are both safe and effective methods for the treatment of liver metastases with MWA generating greater volumes of ablation. No significant differences were found for overall survival, rate of neoplasm, or major complications between both groups.
Colorectal cancer (CRC) is one of the most common tumor entities worldwide and a common cause of cancer-associated death. Colorectal cancer liver metastases (CRLM) thereby constitute a severe life-limiting factor. The therapy of CRLM presents a major challenge and surgical resection as well as systemic chemotherapy remain the first-line treatment options. Over the years several locoregional, vascular- and image-based treatments offered by interventional radiologists have emerged when conventional therapies fail, or metastases recurrence occurs. Among such options is the conventional/traditional transarterial chemoembolization (cTACE) by local injection of a combination of chemotherapeutic- and embolic-agents. A similar treatment is the more recent irinotecan-loaded drug-eluting beads TACE (DEBIRI-TACE), which are administered using the same approach. Numerous studies have shown that these different types of chemoembolization can be applied in different clinical settings safely. Furthermore, such treatments can also be combined with other local or systemic therapies. Unfortunately, due to the incoherent patient populations of studies investigating TACE in CRLM, critics state that the definite evidence supporting positive patient outcomes is still lacking. In the following article we review studies on conventional and DEBIRI-TACE. Although highly dependent on the clinical setting, prior therapies and generally the study population, cTACE and DEBIRI-TACE show comparable results. We present the most representative studies on the different chemoembolization procedures and compare the results. Although there is compelling evidence for both approaches, further studies are necessary to determine which patients profit most from these therapies. In conclusion, we determine TACE to be a viable option in CRLM in different clinical settings. Nevertheless, a multidisciplinary approach is desired to offer patients the best possible care.
Case report of rare congenital cardiovascular anomalies associated with truncus arteriosus type 2
(2022)
Truncus arteriosus (TA) is a very rare congenital anomaly with complex cardiovascular anatomy and high lethality also due to severe associated anatomical variants and pathologies. As TA has a massive impact on the survival of a newborn and usually has to be surgically treated. Thus, it is of high importance to understand this congenital cardiovascular disease and associated complications, to improve life expectancy and outcome of these patients. We recently came across a newborn female patient with a rare complex case of persistent TA type 2 associated with further complex cardiovascular anomalies, who received a contrast enhanced CT scan on the 3 rd day post-partum, showing complex cardiovascular abnormalities that were ultimately incompatible with life.